IndieBio

NanoPlume is a biomaterial company specializing in the large-scale production of innovative biomaterials, notably Bio-Aerogel. It manufactures advanced insulating biomaterials and aerogels, designed to enhance energy and space efficiency, and promote circularity across various industries. The company employs organic and recycled feedstocks, along with green technology, to minimize waste and reduce energy consumption. Its products aim to improve cold chain logistics by insulating cargo boxes, reducing payload and energy consumption, and extending battery range.

Minutia is focused on developing innovative solutions for Type 1 Diabetes through stem cell-derived transplants that incorporate nanosensors. The company specializes in creating subcutaneous insulin-producing cell transplants that are immune-evasive and capable of real-time monitoring via proprietary cell-based sensors. This approach aims to address common challenges associated with transplants and seeks to provide a functional cure for diabetes. By advancing both transplantation techniques and monitoring capabilities, Minutia aspires to transform the clinical landscape of diabetes management and cell replacement therapies.

BioMetallum is a biomining company specializing in sustainable metal extraction. It designs and develops solutions, primarily focused on lithium, using microorganisms to enhance efficiency and minimize environmental impact. The company's services promote a circular economy, aiming to enable a healthier, more sustainable society.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Unibaio specializes in biodegradable nano-encapsulation technology aimed at optimizing agrochemical delivery while minimizing environmental impact. The company develops innovative materials that create micro-nanocapsules, which enhance the efficacy of fertilizers and pesticides by improving their uptake and reducing harmful chemical runoff. Unibaio's solutions enable pesticide manufacturers to adjust their formulations to comply with stringent environmental regulations without altering the active ingredients used by farmers. By using natural compounds such as shrimp waste and clay, Unibaio promotes a circular economy, contributing to lower application costs for farmers and improved agricultural yields. Their technology is applicable across various pesticide and fertilizer types, including traditional chemicals and organic options, ultimately supporting the agricultural sector in reducing toxicity and enhancing the health of crops.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Vader Nanotechnologies specializes in developing organisms and enzymes aimed at addressing environmental challenges related to plastic waste and persistent chemicals like PFAS. The company employs advanced techniques, including automation, image processing, and analytical chemistry, to identify and optimize strains capable of thriving on these difficult-to-degrade substances. By utilizing directed evolution methods, Vader enhances the performance of these organisms, ultimately contributing to more effective recycling processes and the degradation of harmful chemicals. This innovative approach seeks to provide solutions to pressing environmental and health issues.

BioFeyn focuses on enhancing aquaculture by optimizing the feed for farmed fish. The company employs a specialized method of biodegradable nanoencapsulation that surrounds trace amounts of marine ingredients with naturally-derived compounds. This innovative approach improves digestion, absorption, and bioavailability of nutrients, ensuring that fish receive what they naturally consume in the ocean. By delivering essential nutrients and natural disease preventatives through a targeted delivery mechanism, BioFeyn aims to improve fish health and reduce environmental pollution. This method not only contributes to the sustainability of fish farming but also helps produce more nutritious fish for consumers.

Kraken Sense specializes in an automated pathogen detection platform that utilizes advanced nanotechnology and real-time qPCR technology to identify bacterial contamination. The company's innovative solution allows for autonomous sampling from various sources, including liquids, solids, and aerosols. Its user-friendly IoT-enabled dashboard and analytics tools facilitate low-cost monitoring, making pathogen detection accessible and efficient. By employing state-of-the-art calibration techniques and cloud-based encryption, Kraken Sense enables clients to monitor and respond to contamination in real-time, ensuring a safer environment across multiple applications.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

BioAesthetics LLC, founded in 2015 as a spin-out from Tulane University, is focused on developing innovative reconstruction options for breast cancer patients following mastectomies. The company specializes in a tissue-engineered nipple-areolar complex (NAC) that serves as an acellular graft to be used by plastic and reconstructive surgeons during the breast reconstruction phase. This product allows the patient's own cells to integrate with the graft, facilitating the regeneration of a natural nipple and areola. Currently in the pre-clinical phase, this patent-pending technology aims to provide a more effective and aesthetically pleasing solution for patients who have experienced incomplete or removed NACs due to illness, surgery, or congenital conditions. BioAesthetics is headquartered in Research Triangle Park, North Carolina.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company offers innovative biological nanofiltration systems that are significantly more efficient than traditional methods, enabling selective targeting of pollutants and bacteria. These biodegradable and cost-effective systems are designed for rapid scalability, making them suitable for deployment in urban areas facing severe pollution challenges. ViaeX's technology has evolved from extensive research conducted at prestigious institutions, allowing it to address critical issues related to water and air pollution, which contribute to millions of deaths and significant economic losses annually. The company serves a diverse range of clients, including municipalities, governments, and industries worldwide, providing environmentally friendly filtration solutions that enhance energy efficiency and sustainability.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and based in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that leverages proprietary nanoparticles with a unique multilayered structure. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's drug delivery systems are designed to enhance the specificity, efficacy, and safety of cancer treatments, providing healthcare providers with improved tools for targeted therapy.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company offers innovative biological nanofiltration systems that are significantly more efficient than traditional methods, enabling selective targeting of pollutants and bacteria. These biodegradable and cost-effective systems are designed for rapid scalability, making them suitable for deployment in urban areas facing severe pollution challenges. ViaeX's technology has evolved from extensive research conducted at prestigious institutions, allowing it to address critical issues related to water and air pollution, which contribute to millions of deaths and significant economic losses annually. The company serves a diverse range of clients, including municipalities, governments, and industries worldwide, providing environmentally friendly filtration solutions that enhance energy efficiency and sustainability.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and based in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that leverages proprietary nanoparticles with a unique multilayered structure. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's drug delivery systems are designed to enhance the specificity, efficacy, and safety of cancer treatments, providing healthcare providers with improved tools for targeted therapy.